A Victorian man has been admitted to hospital with blood clots just a few days after receiving the AstraZeneca vaccine.
The man received his vaccine dose on March 22 and presented to Melbourne’s Box Hill Hospital on Good Friday with fever and abdominal pain, The Australian reported.
He was found to have abdominal clots with a very low platelet count.
The country’s Health Protection Principal Committee met today and is reportedly discussing the Melbourne case.
Deputy Chief Medical Officer Professor Michael Kidd is expected to give an update after 3pm AEDT.
The World Health Organisation and the EU’s health watchdog have both deemed the AstraZeneca vaccine safe after fears were raised of the jab having serious side effects.
Germany recently announced they were restricting vaccine doses for people under 65 after reports of people with “very rare but very serious cases of thrombosis (blood clots)”.
In March, the European Medicines Agency (EMA) said the shot was not linked to an increased risk of blood clots.
However, the EMA’s report noted it may be associated with clots linked to thromocytopenia, a rare but serious condition involving low levels of blood platelets.
The Australian Technical Advisory Group said there would be no change to the clinical guidance on the use of the AstraZeneca vaccine as a result of the EMA’s findings.
In a statement they said: “ATAGI considers the benefits of vaccination in protecting people in Australia from COVID-19 outweigh the rare potential risk of these rare blood clotting events, and supports the continued rollout of the AstraZeneca vaccine in Australia.”